Zobrazeno 1 - 10
of 1 022
pro vyhledávání: '"Gedrich, R."'
Autor:
Gough SM; Arvinas Operations, Inc., New Haven, Connecticut., Flanagan JJ; Arvinas Operations, Inc., New Haven, Connecticut., Teh J; Arvinas Operations, Inc., New Haven, Connecticut., Andreoli M; Arvinas Operations, Inc., New Haven, Connecticut., Rousseau E; Arvinas Operations, Inc., New Haven, Connecticut., Pannone M; Arvinas Operations, Inc., New Haven, Connecticut., Bookbinder M; Arvinas Operations, Inc., New Haven, Connecticut., Willard R; Arvinas Operations, Inc., New Haven, Connecticut., Davenport K; Arvinas Operations, Inc., New Haven, Connecticut., Bortolon E; Arvinas Operations, Inc., New Haven, Connecticut., Cadelina G; Arvinas Operations, Inc., New Haven, Connecticut., Gordon D; Arvinas Operations, Inc., New Haven, Connecticut., Pizzano J; Arvinas Operations, Inc., New Haven, Connecticut., Macaluso J; Arvinas Operations, Inc., New Haven, Connecticut., Soto L; Arvinas Operations, Inc., New Haven, Connecticut., Corradi J; Arvinas Operations, Inc., New Haven, Connecticut., Digianantonio K; Arvinas Operations, Inc., New Haven, Connecticut., Drulyte I; Thermo Fisher Scientific, Materials and Structural Analysis, Eindhoven, Netherlands., Morgan A; Arvinas Operations, Inc., New Haven, Connecticut., Quinn C; Arvinas Operations, Inc., New Haven, Connecticut., Békés M; Arvinas Operations, Inc., New Haven, Connecticut., Ferraro C; Arvinas Operations, Inc., New Haven, Connecticut., Chen X; Arvinas Operations, Inc., New Haven, Connecticut., Wang G; Arvinas Operations, Inc., New Haven, Connecticut., Dong H; Arvinas Operations, Inc., New Haven, Connecticut., Wang J; Arvinas Operations, Inc., New Haven, Connecticut., Langley DR; Arvinas Operations, Inc., New Haven, Connecticut., Houston J; Arvinas Operations, Inc., New Haven, Connecticut., Gedrich R; Arvinas Operations, Inc., New Haven, Connecticut., Taylor IC; Arvinas Operations, Inc., New Haven, Connecticut.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3549-3563.
Autor:
Fasching, P.A., Clifton, K., Katashvili, Z., Nemsadze, G., Makharadze, T., Arkania, E., Gogishvili, M., Lachowicz, M., Gedrich, R., Ranciato, J., Zhi, E., Perkins, J., Jañez, N. Martinez, Hurvitz, S.A.
Publikováno v:
In ESMO Open May 2023 8(1) Supplement 4
Autor:
Philipovskiy, A., Schott, A., Cortés, J., Ivie, S., Gedrich, R., Zhi, E., Ranciato, J., Perkins, J., Hamilton, E.
Publikováno v:
In ESMO Open May 2023 8(1) Supplement 4
Autor:
Hurvitz, S.A., Schott, A., Ma, C.X., Nanda, R., Zahrah, G., Hunter, N., Tan, A., Telli, M.L., Anampa, J., Jeselsohn, R., Munster, P., Zhi, E., Gedrich, R., Mather, C., Han, H., Hamilton, E.
Publikováno v:
In ESMO Open May 2023 8(1) Supplement 4
Autor:
Alvarado, D., Maurer, Marcus, Gedrich, R., Seibel, S.B., Murphy, M.B., Crew, L., Goldstein, J., Crocker, A., Vitale, L.A., Morani, P.A., Thomas, L.J., Hawthorne, T.R., Keler, T., Young, D., Crowley, E., Kankam, M., Heath-Chiozzi, M.
Background: Mast cells (MC) are powerful inflammatory immune sentinel cells that drive numerous allergic, inflammatory, and pruritic disorders when activated. MC-targeted therapies are approved in several disorders, yet many patients have limited ben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::4baf91f646f6af3c5e24a1fb108e1468
https://publica.fraunhofer.de/handle/publica/429749
https://publica.fraunhofer.de/handle/publica/429749
Autor:
Hamilton, E.P., Han, H., Schott, A., Tan, A., Nanda, R., Juric, D., Hunter, N., Munster, P., Fang, B., Zahrah, G., Ranciato, J., Gedrich, R., Zhi, E., Zhang, Y., Tan, W., Mather, C., Perkins, J., Anderson, S., Hurvitz, S.A.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S344-S344
Autor:
Petrylak, D.P., Garmezy, B., Shen, J., Rezazadeh Kalebasty, A., Sartor, O., Dreicer, R., Agarwal, N., Hussain, M., Percent, I., Heath, E., Gedrich, R., Yu, T., Healey, D., Parameswaran, J., Sternberg, C.N., Gao, X.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S973-S974
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S1188-S1188
Autor:
Alvarado D; Celldex Therapeutics, Hampton, New Jersey, USA., Maurer M; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universtätsmedizin Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany., Gedrich R; Celldex Therapeutics, Hampton, New Jersey, USA., Seibel SB; Celldex Therapeutics, Hampton, New Jersey, USA., Murphy MB; Celldex Therapeutics, Hampton, New Jersey, USA., Crew L; Celldex Therapeutics, Hampton, New Jersey, USA., Goldstein J; Celldex Therapeutics, Hampton, New Jersey, USA., Crocker A; Celldex Therapeutics, Hampton, New Jersey, USA., Vitale LA; Celldex Therapeutics, Hampton, New Jersey, USA., Morani PA; Celldex Therapeutics, Hampton, New Jersey, USA., Thomas LJ; Celldex Therapeutics, Hampton, New Jersey, USA., Hawthorne TR; Celldex Therapeutics, Hampton, New Jersey, USA., Keler T; Celldex Therapeutics, Hampton, New Jersey, USA., Young D; Celldex Therapeutics, Hampton, New Jersey, USA., Crowley E; Celldex Therapeutics, Hampton, New Jersey, USA., Kankam M; Altasciences Clinical Kansas, Overland Park, Kansas, USA., Heath-Chiozzi M; Celldex Therapeutics, Hampton, New Jersey, USA.
Publikováno v:
Allergy [Allergy] 2022 Aug; Vol. 77 (8), pp. 2393-2403. Date of Electronic Publication: 2022 Mar 03.
Autor:
Bauman JE; Division of Hematology/Oncology, Department of Medicine, University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.; Division of Hematology/Oncology, Department of Medicine, GW Cancer Center, The George Washington University, Washington, DC 20052, USA., Julian R; Division of Hematology/Oncology, Department of Medicine, University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA., Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA., Wise-Draper TM; Division of Hematology/Oncology, Department of Medicine, University of Cincinnati Cancer Center, University of Cincinnati, Cincinnati, OH 45267, USA., Adkins DR; Division of Hematology/Oncology, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA., O'Brien P; Division of Hematology/Oncology, Department of Medicine, MUSC Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA., Fidler MJ; Department of Internal Medicine, Rush University Medical Center, Chicago, IL 60612, USA., Gibson MK; Division of Hematology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Duvvuri U; Division of Head and Neck Surgery, Department of Otolaryngology, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA 15232, USA., Heath-Chiozzi M; Celldex Therapeutics, Hampton, NJ 08827, USA., Alvarado D; Celldex Therapeutics, Hampton, NJ 08827, USA., Gedrich R; Celldex Therapeutics, Hampton, NJ 08827, USA., Golden P; Celldex Therapeutics, Hampton, NJ 08827, USA., Cohen RB; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2022 May 10; Vol. 14 (10). Date of Electronic Publication: 2022 May 10.